ATE250858T1 - Implantierbare agarose-kollagenkügelchen enthaltende zellen, die ein diffusionsfähiges biologisches produkt bilden und ihre verwendung - Google Patents

Implantierbare agarose-kollagenkügelchen enthaltende zellen, die ein diffusionsfähiges biologisches produkt bilden und ihre verwendung

Info

Publication number
ATE250858T1
ATE250858T1 AT97915180T AT97915180T ATE250858T1 AT E250858 T1 ATE250858 T1 AT E250858T1 AT 97915180 T AT97915180 T AT 97915180T AT 97915180 T AT97915180 T AT 97915180T AT E250858 T1 ATE250858 T1 AT E250858T1
Authority
AT
Austria
Prior art keywords
biological product
diffusable
agarose
cells containing
containing agarose
Prior art date
Application number
AT97915180T
Other languages
English (en)
Inventor
Kanti Jain
Albert L Rubin
Shirin Asina
Barry Smith
Kurt Stenzel
Original Assignee
Rogosin Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/745,063 external-priority patent/US5888497A/en
Application filed by Rogosin Inst filed Critical Rogosin Inst
Application granted granted Critical
Publication of ATE250858T1 publication Critical patent/ATE250858T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
AT97915180T 1996-04-03 1997-03-21 Implantierbare agarose-kollagenkügelchen enthaltende zellen, die ein diffusionsfähiges biologisches produkt bilden und ihre verwendung ATE250858T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62559596A 1996-04-03 1996-04-03
US08/745,063 US5888497A (en) 1996-04-03 1996-11-07 Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation
PCT/US1997/004548 WO1997036495A1 (en) 1996-04-03 1997-03-21 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof

Publications (1)

Publication Number Publication Date
ATE250858T1 true ATE250858T1 (de) 2003-10-15

Family

ID=27089961

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03018701T ATE374034T1 (de) 1996-04-03 1997-03-21 Konditioniertes medium und diffusionsfähiges biologisches material gewonnen durch inkubierung von eingeschlossenen zellen
AT97915180T ATE250858T1 (de) 1996-04-03 1997-03-21 Implantierbare agarose-kollagenkügelchen enthaltende zellen, die ein diffusionsfähiges biologisches produkt bilden und ihre verwendung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT03018701T ATE374034T1 (de) 1996-04-03 1997-03-21 Konditioniertes medium und diffusionsfähiges biologisches material gewonnen durch inkubierung von eingeschlossenen zellen

Country Status (15)

Country Link
EP (2) EP0914043B1 (de)
JP (2) JP3765039B2 (de)
CN (2) CN1296477C (de)
AT (2) ATE374034T1 (de)
AU (1) AU722109C (de)
CA (1) CA2250880C (de)
DE (2) DE69725317T2 (de)
DK (2) DK0914043T3 (de)
ES (2) ES2290390T3 (de)
FI (1) FI120332B (de)
IL (1) IL126442A0 (de)
NO (1) NO320334B1 (de)
NZ (2) NZ331960A (de)
PT (1) PT914043E (de)
WO (1) WO1997036495A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297331B2 (en) 1996-04-03 2007-11-20 The Rogosin Institute Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
US6303151B1 (en) * 1996-04-03 2001-10-16 The Rogosin Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US6224912B1 (en) * 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
NO983911D0 (no) 1998-08-26 1998-08-26 Norsk Hydro As Alginatkapsler til bruk ved behandling av hjernesvulst
AU2003264652B2 (en) * 1998-11-09 2006-09-14 The Rogosin Institute Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof
US8257715B1 (en) 2004-08-26 2012-09-04 University Of Notre Dame Tissue vaccines and uses thereof
US8802113B2 (en) 2005-10-27 2014-08-12 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US9308252B2 (en) 2005-10-27 2016-04-12 Cook Biotech, Inc. Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
US8778360B2 (en) * 2005-10-27 2014-07-15 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US8778362B2 (en) 2005-10-27 2014-07-15 University Of Notre Dame Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
US9283266B2 (en) 2008-02-28 2016-03-15 University Of Notre Dame Metastasis inhibition preparations and methods
US8846059B2 (en) 2009-12-08 2014-09-30 University Of Notre Dame Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer
NZ624195A (en) * 2012-01-31 2015-07-31 Rogosin Inst Improved method for manufacture of macrobeads
US12038432B2 (en) 2018-02-02 2024-07-16 Wake Forest University Health Sciences Organoids related to immunotherapy and methods of preparing and using the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE441009B (sv) * 1982-03-08 1985-09-02 Kjell Nilsson Sett att immobilisera levande biomaterial i perlformiga polymerer
US4798786A (en) * 1982-05-06 1989-01-17 Stolle Research And Development Corporation Living cells encapsulated in crosslinked protein
CA1196862A (en) * 1983-06-01 1985-11-19 Connaught Laboratories Limited Microencapsulation of living tissue and cells
US4663286A (en) * 1984-02-13 1987-05-05 Damon Biotech, Inc. Encapsulation of materials
SE8604684L (sv) * 1986-11-03 1988-05-04 Excorim Kommanditbolag Sett att belegga fasta partiklar med en hydrofil gel samt genom settet belagda partiklar
JP2691557B2 (ja) * 1988-04-15 1997-12-17 興研株式会社 人の悪性腫瘍細胞増殖抑制剤
US5053332A (en) * 1989-07-24 1991-10-01 Cook Richard B Agarose beads, preferably incorporating biological materials
US5241051A (en) * 1992-04-24 1993-08-31 Research Development Foundation Oncoinhibin
DK1666585T3 (da) * 1994-01-13 2009-01-12 Rogosin Inst Makroindkapslede sekretoriske celler
US5651980A (en) * 1994-04-15 1997-07-29 Biohybrid Technologies, Inc. Methods of use of uncoated gel particles

Also Published As

Publication number Publication date
WO1997036495A1 (en) 1997-10-09
CN1119080C (zh) 2003-08-27
NO320334B1 (no) 2005-11-21
DK0914043T3 (da) 2004-02-09
CN1495253A (zh) 2004-05-12
CA2250880A1 (en) 1997-10-09
JP3765039B2 (ja) 2006-04-12
FI981957A0 (fi) 1998-09-11
EP1382346A1 (de) 2004-01-21
IL126442A0 (en) 1999-08-17
FI981957L (fi) 1998-12-02
CN1296477C (zh) 2007-01-24
NZ331960A (en) 1999-10-28
EP1382346B1 (de) 2007-09-26
HK1066026A1 (en) 2005-03-11
FI120332B (fi) 2009-09-30
DE69738170T2 (de) 2008-01-24
AU722109C (en) 2001-07-19
ATE374034T1 (de) 2007-10-15
ES2206696T3 (es) 2004-05-16
NZ337109A (en) 2004-12-24
AU2218897A (en) 1997-10-22
NO984627L (no) 1998-11-30
CA2250880C (en) 2008-01-15
DK1382346T3 (da) 2008-01-28
EP0914043B1 (de) 2003-10-01
JP2005104987A (ja) 2005-04-21
PT914043E (pt) 2004-02-27
HK1019037A1 (en) 2000-01-21
NO984627D0 (no) 1998-10-02
EP0914043A1 (de) 1999-05-12
JP2001503380A (ja) 2001-03-13
JP4480152B2 (ja) 2010-06-16
CN1215309A (zh) 1999-04-28
AU722109B2 (en) 2000-07-20
EP0914043A4 (de) 2001-08-29
DE69738170D1 (de) 2007-11-08
DE69725317D1 (de) 2003-11-06
DE69725317T2 (de) 2004-07-29
ES2290390T3 (es) 2008-02-16

Similar Documents

Publication Publication Date Title
ATE250858T1 (de) Implantierbare agarose-kollagenkügelchen enthaltende zellen, die ein diffusionsfähiges biologisches produkt bilden und ihre verwendung
CA2285430A1 (en) Calcium phosphate microcarriers and microspheres
FI963101A7 (fi) Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoo n, joissa seerumin interleukiini-6-taso on kohonnut
EP0279862A4 (de) Zelltoxischer antikörperkomplex und verfahren zu seiner herstellung.
ATE383344T1 (de) Pyridazin-3-on derivate, deren verwendung und zwischenprodukte für deren herstellung
DE69132352D1 (de) Protein-antagonisten der blut-koagulation und ihre verwendung
DE69633135D1 (de) Fluorierte oniumsatze, härtbare zusammensetzungen, welche selbige enthalten, und härtungsverfahren unter deren verwendung
ATE26450T1 (de) Mukopolysaccharide mit biologischen eigenschaften, ihre herstellung und verwendung als arzneimittel.
DE69927268D1 (de) Spezifische antikörper enthaltende bindungsproteine die das nekrotische tumorzentrum binden und deren verwendung
DE69102903D1 (de) Überzogenes Vitamin-C-Präparat für Tierfutter, dessen Herstellung und Verwendung.
ATE73758T1 (de) 2,2-difluorcyclopropylethanderivate, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel.
WO2000004865A3 (en) Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives
EP0296441A3 (de) Verwendung von unlöslichen, polyfunktionellen quartären Ammoniumverbindungen zur adsorptiven Bindung von Mikroorganismen
DE59306681D1 (de) Neue ketoester-reduktase, deren herstellung und verwendung für enzymatische redoxreaktionen
ATE242770T1 (de) Neue alpha-hydroxysäurederivate, ihre herstellung und verwendung
DE69600043D1 (de) Expandiertes festes Produkt auf Basis von Stärke, das kugelähnliche bestimmte Grösse enthält sowie seiner Anwendung zur topischen Verwendung
EP0585464A4 (de) Stark wasserabdorbierender reis, verfahren zur dessen herstellung und verwendung.
DE69413183D1 (de) Indazolsulfonylharnstoff-derivat, verwendung und zwischenprodukte zur herstellung
DE69426723D1 (de) Nährboden zur Züchtung tierischer Zellen oder Zellen die Antikörper produzieren
DE3687515D1 (de) Oxa-, thia- und diazabicycloalkanderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
NL192291B (nl) Werkwijze voor het maken van een fermentproduct, daarmee verkregen korrelvormig fermentproduct en toepassing van het fermentproduct.
ATE432292T1 (de) Antitumorantikörper, proteine und deren verwendung
EP0774469A3 (de) Acylierte Saccharosemonocarbonsäuren
ATE212331T1 (de) Phenylessigsäurederivate, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen und tierischen schädlingen
ATE193523T1 (de) Cyaniminooximether, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen und tierischen schädlingen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0914043

Country of ref document: EP